‌

US Patent 11702389 Piperidine derivatives as HDAC1/2 inhibitors

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Regenacy Pharmaceuticals

0

Current Assignee

Regenacy Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 18, 2023

0

Patent Application Number

171841180

Date Filed

February 24, 2021

0

Patent Citations

US Patent 8394810 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof

0

US Patent 8598168 Inhibitors of histone deacetylase

0

US Patent 8609678 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof

0

US Patent 8614223 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof

0

US Patent 9096549 Selective HDAC3 inhibitors

0

US Patent 9139583 Selective HDAC3 inhibitors

0

US Patent 9145412 Selective HDAC1 and HDAC2 inhibitors

0

US Patent 9249087 HDAC inhibitors and therapeutic methods using the same

0

...

Patent Primary Examiner

Theodore R. Howell

0

CPC Code

0

0

0

0

0

0

Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11702389 Piperidine derivatives as HDAC1/2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.